| |
| |
|
| Insider
Information: |
Betz Stephen F. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
86,643 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,847,816 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
86,643 |
|
|
| Total
Value |
$3,847,816 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crinetics Pharmaceuticals, Inc. |
CRNX |
|
2024-05-28 |
86,643 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific OfficerOffice |
• – – |
2021-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
187,925 |
|
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-10-21 |
4 |
AS |
$21.10 |
$21,984 |
D/D |
(1,042) |
186,883 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-09-07 |
4 |
AS |
$21.00 |
$21,884 |
D/D |
(1,042) |
104,766 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-05-20 |
4 |
A |
$11.02 |
$14,723 |
D/D |
1,336 |
108,934 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-03-16 |
4 |
D |
$17.12 |
$24,139 |
D/D |
(1,410) |
86,879 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-11-16 |
4 |
AS |
$27.97 |
$41,955 |
D/D |
(1,500) |
154,547 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-10-27 |
4 |
AS |
$24.00 |
$71,991 |
D/D |
(3,000) |
183,883 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2021-12-28 |
4 |
AS |
$27.95 |
$83,852 |
D/D |
(3,000) |
140,211 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-11-27 |
4 |
AS |
$31.84 |
$95,520 |
D/D |
(3,000) |
85,298 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-12-11 |
4 |
AS |
$32.87 |
$98,610 |
D/D |
(3,000) |
82,298 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2023-12-26 |
4 |
AS |
$35.89 |
$107,670 |
D/D |
(3,000) |
79,298 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2024-01-10 |
4 |
AS |
$37.65 |
$112,950 |
D/D |
(3,000) |
76,298 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2024-01-25 |
4 |
AS |
$37.26 |
$111,780 |
D/D |
(3,000) |
73,298 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2024-05-10 |
4 |
AS |
$49.43 |
$148,290 |
D/D |
(3,000) |
89,643 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2024-05-28 |
4 |
AS |
$47.49 |
$142,470 |
D/D |
(3,000) |
86,643 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-02-01 |
4 |
AS |
$18.79 |
$58,681 |
D/D |
(3,123) |
126,706 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-02-15 |
4 |
AS |
$18.64 |
$58,213 |
D/D |
(3,123) |
123,583 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-03-01 |
4 |
AS |
$19.73 |
$61,617 |
D/D |
(3,123) |
136,960 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-03-15 |
4 |
AS |
$18.94 |
$59,150 |
D/D |
(3,123) |
133,837 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-09-01 |
4 |
AS |
$18.59 |
$58,112 |
D/D |
(3,126) |
105,808 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-10-03 |
4 |
AS |
$19.64 |
$61,395 |
D/D |
(3,126) |
97,472 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-10-17 |
4 |
AS |
$17.73 |
$55,424 |
D/D |
(3,126) |
94,346 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-11-01 |
4 |
AS |
$18.52 |
$57,894 |
D/D |
(3,126) |
91,220 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-11-15 |
4 |
AS |
$18.72 |
$58,519 |
D/D |
(3,126) |
88,094 |
0 |
% |
|
| CRNX |
Crinetics Pharmaceuticals... |
Chief Scientific Officer |
• – – |
2022-12-01 |
4 |
AS |
$17.84 |
$55,768 |
D/D |
(3,126) |
84,968 |
0 |
% |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
